Alto Ingredients, INC
Market Movers (8-K)
NASDAQ
Alto Ingredients Inc. announced first quarter 2026 results showing a significant improvement in net income and Adjusted EBITDA compared to the prior year, driven by strong export sales and tax credits.
NASDAQ
Alto Ingredients, Inc. reported significantly improved financial results for Q4 and full-year 2025, driven by strategic realignment and higher crush margins.
Better than expected
NASDAQ
Jeremy T. Bezdek has resigned from his position as a member of the Board of Directors of Alto Ingredients, Inc., effective November 24, 2025.
NASDAQ
Alto Ingredients reported significantly improved financial results for Q3 2025, driven by strategic initiatives, increased demand for liquid CO2, and higher renewable fuel export sales.
Better than expected
NASDAQ
Alto Ingredients, Inc. reported a net loss of $11.3 million for Q2 2025, or $0.15 per share, despite improved gross profit from Western assets and reduced SG&A expenses.
Delay expected
Worse than expected
NASDAQ
Alto Ingredients, Inc. announced it has successfully regained compliance with Nasdaq's minimum bid price requirement, closing the matter of its continued listing.
Better than expected
Quarterly Earnings (10-Q)
NASDAQ
Alto Ingredients reported a significant turnaround in Q1 2026, achieving net income and positive Adjusted EBITDA driven by improved crush margins, higher-value product mix, and Section 45Z clean fuel tax credits.
Better than expected
Delay expected
NASDAQ
Alto Ingredients reported a significant turnaround in Q3 2025, achieving net income of $14.2 million and a 294% gross profit increase, driven by strategic realignment, higher-margin exports, and CO2 business growth.
Delay expected
Better than expected
NASDAQ
Alto Ingredients reported a wider net loss in the second quarter of 2025, primarily due to non-cash hedging impacts and operational disruptions, despite improvements in Adjusted EBITDA and Western segment profitability.
Worse than expected
Capital raise
Delay expected
NASDAQ
Alto Ingredients reports a narrower gross loss and improved Adjusted EBITDA for Q1 2025, driven by cost-saving measures and strategic initiatives, despite a decrease in net sales.
Better than expected
NASDAQ
Alto Ingredients experienced a decrease in net sales but an improvement in gross profit in the third quarter of 2024, while navigating fluctuating market conditions and strategic operational adjustments.
Worse than expected
Capital raise
NASDAQ
10-Q: Alto Ingredients Reports Mixed Q2 Results Amidst Operational Improvements and Market Headwinds
Alto Ingredients experienced a challenging second quarter with a net loss, despite operational improvements at its Pekin campus and increased specialty alcohol sales.
Delay expected
Capital raise
Worse than expected
Annual Reports (10-K)
NASDAQ
Alto Ingredients achieved significant financial improvements in 2025, driven by increased crush margins, Section 45Z tax credits, and strategic focus on specialty alcohols and essential ingredients, despite a decline in overall sales volumes.
Better than expected
Delay expected
NASDAQ
10-K: Alto Ingredients Navigates Challenging Market, Focuses on Strategic Realignment and Carbon Capture
Alto Ingredients reports a challenging year with strategic shifts including facility idling and asset exploration, while prioritizing carbon capture initiatives.
Worse than expected
NASDAQ
Alto Ingredients, a renewable fuel and specialty alcohol producer, announced its 2023 financial results, highlighting a shift towards specialty alcohols and a focus on carbon capture and storage.
Better than expected
Delay expected
Insider Trading (Form 4)
NASDAQ
Alto Ingredients, Inc. Director Dianne S. Nury reported the acquisition of 23,605 shares of common stock on June 23, 2026.
NASDAQ
Alto Ingredients, Inc. reports a significant share acquisition by Director Nathan Gilbert E, increasing his direct beneficial ownership.
NASDAQ
Alto Ingredients, Inc. Director Alan Robert Tank reported the acquisition of 23,605 shares of common stock on June 23, 2026.
NASDAQ
Alto Ingredients, Inc. reports a Form 4 filing detailing a significant acquisition of common stock by Director Maria G. Gray.
NASDAQ
Alto Ingredients CLO & Secretary, Auste M. Graham, reported a charitable gift of 20,000 common shares.
NASDAQ
Director Gilbert E. Nathan of Alto Ingredients, Inc. has reported the acquisition of 20,000 shares of common stock.
Proxy Statements (Def-14A)
NASDAQ
Alto Ingredients, Inc. reported a significant financial turnaround in 2025, driven by strategic initiatives, increased net income, and strong Adjusted EBITDA growth.
Better than expected
NASDAQ
Alto Ingredients, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
DEF 14A: Alto Ingredients Focuses on Efficiency and Strategic Transactions Amidst Difficult Market Conditions
Alto Ingredients, Inc. is streamlining operations and exploring strategic transactions to enhance long-term stockholder value amidst persistent difficult market conditions.
Worse than expected
NASDAQ
Alto Ingredients, Inc. has filed a definitive proxy statement pursuant to Section 14(a) of the Securities Exchange Act of 1934.
NASDAQ
Alto Ingredients is asking stockholders to vote on key proposals at the 2024 annual meeting, including electing directors and approving an amendment to the 2016 Stock Incentive Plan.
Worse than expected
Delay expected
Schedule 13D - Activist Investments
NASDAQ
SCHEDULE 13D/A: Alto Ingredients Reaches Agreement with Activist Investors, Board Refreshment Underway
Alto Ingredients, Inc. has announced a settlement agreement with the Radoff/Torok Group, leading to board changes and the termination of the activist group's collective beneficial ownership.
NASDAQ
SCHEDULE 13D: Activist Investors Radoff and Torok Group to Push for Strategic Review and Board Refresh at Alto Ingredients
A group of activist investors, including Bradley L. Radoff and Michael Torok, have formed a group to collectively own 6.4% of Alto Ingredients, Inc. and intend to push for a strategic review, including a potential sale of the company, and a significant refresh of its Board of Directors.
Schedule 13G - Passive Investments
NASDAQ
DOMO Capital Management, LLC and Justin R. Dopierala have filed an amendment to their Schedule 13G, reporting a reduced beneficial ownership of 3.4% in Alto Ingredients, Inc.
Worse than expected
NASDAQ
DOMO Capital Management, LLC and Justin R. Dopierala have disclosed a 7.1% beneficial ownership stake in Alto Ingredients, Inc., totaling 5,420,069 shares, as of December 31, 2024.